Ivana Jovo Djuran

Dr. Ivana Jovo Djuran

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Ivana Jovo DjuranIvana Jovo Djuran
Ivana Jovo Djuran
BLBojana Ljubicic
Bojana Ljubicic
TATijana Azasevac
Tijana Azasevac
NNNikola Nikolic
Nikola Nikolic
DCDejan Celic
Dejan Celic
VKVioleta Knezevic
Violeta Knezevic
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by exocrine gland dysfunction and heterogeneous extraglandular manifestations. Renal involvement, most frequently distal renal tubular acidosis (dRTA), may present with severe metabolic disturbances. Rhabdomyolysis due to hypokalemia and systemic vasculitis are uncommon but potentially life-threatening complications. We report a 36-year-old woman who presented with fever, profuse diarrhea, progressive proximal muscle weakness, and a 10-kg weight loss. Laboratory evaluation revealed profound hypokalemia, hyperchloremic non-anion gap metabolic acidosis consistent with dRTA, and rhabdomyolysis with creatine phosphokinase (CPK) of 42,000 U/L. Electromyoneurography (EMNG) confirmed inflammatory myopathy, while autoimmune serology was positive for antinuclear antibody (ANA), anti-Ro52, anti-SSA, and anti-proliferating cell nuclear antigen (PCNA) with marked hypocomplementemia. Despite supportive therapy, she developed an acute abdomen. Emergency laparotomy revealed perforated ischemic colitis and gangrenous cholecystitis. Histopathology confirmed necrotizing vasculitis of small- and medium-sized arteries. Treatment included continuous renal replacement therapy (RRT) with cytokine hemoadsorption. After surgical stabilization and histopathological confirmation of necrotizing vasculitis, immunosuppressive therapy was initiated according to the European League Against Rheumatism (EULAR) and Kidney Disease: Improving Global Outcomes (KDIGO) recommendations for the management of severe systemic vasculitis with visceral involvement. The patient received intravenous pulse cyclophosphamide (CYC) at a dose of 800 mg (corresponding to a total induction dose of approximately 2.5-3 g (as recommended for remission induction), combined with high-dose methylprednisolone with gradual tapering. Supportive measures included intravenous hydration, Mesna uroprotection, and antiemetic prophylaxis. The patient showed significant clinical improvement, normalization of electrolyte and laboratory parameters, and functional recovery within two weeks. This case underscores two severe extraglandular phenotypes of pSS: dRTA-induced hypokalemic rhabdomyolysis and fulminant systemic necrotizing vasculitis. Both are rarely reported and carry high morbidity and mortality. Recognition of hypokalemia as a potential trigger for rhabdomyolysis and vigilance for vasculitic complications are crucial for timely diagnosis. Multidisciplinary management, including nephrology, immunology, surgery, and aggressive immunosuppression, proved life-saving. pSS may present with atypical and catastrophic extraglandular involvement. Physicians should maintain a high index of suspicion when encountering metabolic disturbances with multisystem features. Early recognition and coordinated intervention can significantly improve outcomes.

18 June 2026 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
Ivana Jovo DjuranIvana Jovo Djuran
Ivana Jovo Djuran
NKNikola Komazec
Nikola Komazec
BLBojana Ljubičić
Bojana Ljubičić
ALAna Lazarević
Ana Lazarević
SŽSiniša Živković
Siniša Živković
MMMia Manojlović
Mia Manojlović
Cardiovascular disease is a leading cause of mortality in chronic kidney disease (CKD), but whether impaired renal function independently increases coronary artery calcium (CAC) burden in patients with comparable cardiovascular referral indications remains uncertain. This retrospective cross-sectional study included 206 adults who underwent coronary computed tomography angiography (CCTA) with simultaneous Agatston scoring at the Institute for Cardiovascular Diseases of Vojvodina between 2020 and 2025. Patients were classified as having eGFR-defined non-dialysis CKD stages 3–5 (n=110; estimated glomerular filtration rate [eGFR] ≤59 mL/min/1.73 m²) or preserved renal function (n=96; eGFR ≥60 mL/min/1.73 m²). Both groups were drawn from the same cardiovascular referral population. The primary outcome was total Agatston score, while secondary analyses included Agatston severity categories, significant vessel-level stenosis, calcified coronary segment count, eGFR–Agatston correlation, and predictors of severe CAC. Total Agatston scores did not differ significantly between CKD and control groups (median 248.5 vs. 198.0; p=0.240), and severe calcification was similarly frequent (40.0% vs. 41.6%). Vessel-level stenosis, calcified segment distribution, and the eGFR–Agatston correlation were also non-significant. In multivariable logistic regression adjusted for age, sex, hypertension, diabetes, and prior coronary artery bypass grafting (CABG), CKD was not independently associated with severe CAC. However, CKD patients showed a markedly more adverse cardiovascular phenotype, including more hypertension, angina, peripheral arterial disease, prior CABG, lower left ventricular ejection fraction (LVEF), higher right ventricular systolic pressure (RVSP), and more severe valvular disease. These findings suggest that CAC scoring alone does not capture the multidimensional cardiovascular burden of non-dialysis CKD and should be integrated with echocardiographic and systemic vascular assessment in high-risk referral populations.

1 January 2025 in Hospital Pharmacology - International Multidisciplinary Journal
Verified
Journal Article
Open access
AKAna Kalinić
Ana Kalinić
STSlobodan Torbica
Slobodan Torbica
TMTijana Marčeta
Tijana Marčeta
RPRadmila Popović
Radmila Popović
SMSanja Maričić-Prijić
Sanja Maričić-Prijić
BMBoris Milijašević
Boris Milijašević
Introduction: With the increased use of diagnostic procedures such as computed tomography (CT), the detection of asymptomatic adrenal lesions demonstrates a growing trend. Accurately distinguishing these lesions is essential for guiding future diagnostic and treatment approaches. Aim: This study aimed to investigate whether it is possible to determine the adenomatous characteristics of adrenal tumors on non-contrast CT scans. Material and Method: A retrospective observational study was conducted at the University Clinical Center of Vojvodina (UKCV), involving 43 patients who underwent CT imaging following the adrenal protocol. The key parameters examined were: sex, age, antero-posterior (AP) and latero-lateral diameter (LL) of the adenoma, non-contrast density, absolute (APW) and relative (RPW) washout. Results: Our study has shown a statistically significant negative correlation between non-contrast density and RPW (p<0.001), as well as significant positive correlation between APW and RPW (p=0.007). The non-contrast density demonstrated a statistically significant positive correlation with the AP diameter of the adenoma (p=0.035). Conclusion: Our research shows that when using unenhanced CT imaging, a non-contrast density significantly below 10 Hounsfield units (HU) and a lesion diameter under 40 mm strongly suggest an adrenal gland adenoma, potentially allowing for diagnosis without multiple scans or contrast.

1 January 2024 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
NKNikola Komazec
Nikola Komazec
NDNina Dracina
Nina Dracina
MCMilenko Cankovic
Milenko Cankovic
MGMiodrag Golubovic
Miodrag Golubovic
MRMilenko Rosic
Milenko Rosic
Ivana Jovo DjuranIvana Jovo Djuran
Ivana Jovo Djuran
Introduction. Congenital malformations of the mitral valve encompass a broad spectrum of lesions, with an incidence of approximately 0.4% among patients with congenital heart diseases. Case Report. A 45-year-old female was admitted to our institution due to a confirmed mitral valve defect identified via echocardiographic examination. She presented with leg swelling and rapid fatigue. Her medical history includes systemic lupus erythematosus. Upon admission, she was in cardiopulmonary decompensation, with a systolic murmur detected in the mitral valve area, radiating towards the axilla. Transesophageal echocardiographic revealed severe mitral stenosis with moderate regurgitation, without clear visualization of the two cusps. Cardiac computed tomography confirmed a voluminous anterior mitral cusp and a hypoplastic posterior cusp, observed in diastole as a crescent-shaped, characteristic of a unicuspid mitral valve. Follow-up echocardiographic showed progression of mitral regurgitation with circumferential pericardial effusion, necessitating pericardiocentesis. Due to further hemodynamic instability, urgent surgical mitral valve replacement was indicated. The surgery proceeded without complications, but the immediate period was marked by exacerbation of renal impairment, requiring hemodiafiltration on several occasions. Following cardiological stabilization, the patient was transferred to the Nephrology Clinic for further management of renal insufficiency and systemic lupus. Conclusion. It is crucial to emphasize the significance of a multidisciplinary approach for each patient, with particular emphasis on detailed imaging diagnostics to definitively establish a congenital heart disease diagnosis.

29 September 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Ivana Jovo DjuranIvana Jovo Djuran
Ivana Jovo Djuran
BLBojana Ljubicic
Bojana Ljubicic
ALAna Lazarevic
Ana Lazarevic
MPMilica Popovic
Milica Popovic
VKVioleta Knezevic
Violeta Knezevic
Antisynthetase syndrome (ASTS) is an infrequent autoimmune condition marked by chronic inflammation and the presence of autoantibodies targeting aminoacyl-tRNA synthetases. Clinically, it often manifests through a constellation of features, including inflammatory arthritis, myositis, Raynaud's phenomenon, hyperkeratotic skin changes (mechanic's hands), and interstitial lung disease (ILD). Among these, ILD is the most significant in terms of prognosis, as it contributes to elevated rates of morbidity and mortality, surpassing those seen in other idiopathic inflammatory myopathies. We report the clinical course of a 56-year-old woman with a prior diagnosis of systemic lupus erythematosus (SLE) established in 2019, based on the 2017 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria. She was admitted to the Institute for Pulmonary Diseases of Vojvodina (IPBV) in Sremska Kamenica, Serbia, due to respiratory symptoms suggestive of ILD. Although ILD is an uncommon manifestation in SLE, the patient was assessed for the potential coexistence of other connective tissue diseases, such as systemic sclerosis (SSc) and inflammatory myopathies. Laboratory testing demonstrated a strong antinuclear antibody (ANA) reactivity on Hep-2 cells and low anti-double-stranded DNA (anti-dsDNA) levels (<10 IU/ml). Extended myositis panel testing revealed marked positivity for anti-PL-12 and anti-Ro-52 antibodies. Given the presence of pre-existing ILD and clinical signs of arthritis and proximal muscle weakness, alongside the identification of anti-tRNA synthetases antibodies, a diagnosis of ASTS was established. Immunosuppressive treatment was intensified by increasing the glucocorticoid (GC) dosage and introducing intravenous cyclophosphamide (CYC, 1 g). The patient demonstrated a favorable clinical and biochemical response to this regimen.

8 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Ivana Jovo DjuranIvana Jovo Djuran
Ivana Jovo Djuran
BLBojana Ljubičić
Bojana Ljubičić
MNMira Novković
Mira Novković
DMDanilo Medin
Danilo Medin
MKMilica Knezevic
Milica Knezevic
TATijana Azasevac
Tijana Azasevac
Background and Objectives: Cardiovascular disease is the leading cause of mortality in patients with ANCA-associated vasculitis (AAV) after the first year post-diagnosis. This study investigated relationships between traditional risk factors, echocardiographic findings, disease activity, and major adverse cardiovascular events (MACE) in AAV patients. Aim: This retrospective single-center study aimed to evaluate the impact of traditional cardiovascular risk factors and echocardiographic parameters on the occurrence of MACE in patients with AAV. Materials and Methods: This study included adult patients with AAV who were evaluated between 2020 and 2025. Data collected included demographics, cardiovascular risk factors, Birmingham Vasculitis Activity Score version 3 (BVASv3), laboratory parameters, immunosuppressive therapy, and transthoracic echocardiography (TTE) findings. MACE was defined as myocardial infarction, stroke, revascularization, cardiovascular hospitalization, or cardiovascular death. Results: The cohort comprised 32 females (61.5%) and 20 males (38.5%), with a mean age of 62.4 ± 12.4 years. MACE occurred in 38.5% of patients. Male gender (p = 0.002), overweight (p = 0.016), hyperlipidemia (p = 0.003), and prior cardiovascular disease (p = 0.002) were significantly associated with MACE in univariate analyses. Patients with MACE had larger left atrial anteroposterior dimensions on the parasternal long-axis view (median 3.9 vs. 3.3 cm, p = 0.002) and lower left ventricular ejection fraction assessed by the modified biplane Simpson’s method (median 53% vs. 60%, p = 0.002). Valvular dysfunction was not associated with MACE in a statistically significant manner. Disease activity markers (BVASv3 and CRP) showed no significant correlation with cardiovascular events or echocardiographic parameters. Conclusions: Our results demonstrate that traditional cardiovascular risk factors are stronger determinants of MACE in AAV patients than disease-specific parameters. Cardiac structural changes, including left atrial dilation and decreased left ventricular ejection fraction, were significantly associated with cardiovascular outcomes. These findings underscore the importance of integrating systematic cardiovascular risk assessment and aggressive risk factor modification into standard AAV management protocols.